It has been proposed that pharmacological intervention with appropriate antihypertensive agents, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), may be beneficial for cancer patients experiencing hypertension [129]. This evidence concerns the gene ACE and hypertensive disorder.